Euikyung Kim

Prof. Euikyung Kim

pathology, Yale School of Medicine, New Haven, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 1997 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
EKEuikyung Kim
Euikyung Kim
LDLei Du
Lei Du
DBDavid B. Bregman
David B. Bregman
SWStephen L. Warren
Stephen L. Warren
The carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II (Pol II) contains multiple tandem copies of the consensus heptapeptide, TyrSerProThrSerProSer. Concomitant with transcription initiation the CTD is phosphorylated. Elongating polymerase has a hyperphosphorylated CTD, but the role of this modification is poorly understood. A recent study revealed that some hyperphosphorylated polymerase molecules (Pol IIo) are nonchromosomal, and hence transcriptionally unengaged (Bregman, D.B., L. Du, S. van der Zee, S.L. Warren. 1995. J. Cell Biol. 129: 287–298). Pol IIo was concentrated in discrete splicing factor domains, suggesting a possible relationship between CTD phosphorylation and splicing factors, but no evidence beyond immunolocalization data was provided to support this idea. Here, we show that Pol IIo co-immunoprecipitates with members of two classes of splicing factors, the Sm snRNPs and non-snRNP SerArg (SR) family proteins. Significantly, Pol IIo9s association with splicing factors is maintained in the absence of pre-mRNA, and the polymerase need not be transcriptionally engaged. We also provide definitive evidence that hyperphosphorylation of Pol II9s CTD is poorly correlated with its transcriptional activity. Using monoclonal antibodies (mAbs) H5 and H14, which are shown here to recognize phosphoepitopes on Pol II9s CTD, we have quantitated the level of Pol IIo at different stages of the cell cycle. The level of Pol IIo is similar in interphase and mitotic cells, which are transcriptionally active and inactive, respectively. Finally, complexes containing Pol IIo and splicing factors can be prepared from mitotic as well as interphase cells. The experiments reported here establish that hyperphosphorylation of the CTD is a good indicator of polymerase9s association with snRNP and SR splicing factors, but not of its transcriptional activity. Most importantly, the present study suggests that splicing factors may associate with the polymerase via the hyperphosphorylated CTD.

30 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HLHyunkyoung Lee
Hyunkyoung Lee
JKJong-Shu Kim
Jong-Shu Kim
EKEuikyung Kim
Euikyung Kim
Recently there has been an increased interest in the pharmacologically active natural products associated with remedies of various kinds of diseases, including cancer. Fucoidan is a polysaccharide derived from brown seaweeds and has long been used as an ingredient in some dietary supplement products. Although fucoidan has been known to have anti-cancer activity, the anti-metastatic effects and its detailed mechanism of actions have been poorly understood. Therefore, the aims of this study were to demonstrate the anti-metastatic functions of fucoidan and its mechanism of action using A549, a highly metastatic human lung cancer cell line. Fucoidan inhibits the growth of A549 cells at the concentration of 400 µg/ml. Fucoidan treatment of non-toxic dose (0–200 µg/ml) exhibits a concentration-dependent inhibitory effect on the invasion and migration of the cancer cell via decreasing its MMP-2 activity. To know the mechanism of these inhibitory effects, Western blotting was performed. Fucoidan treatment down-regulates extracellular signal-related kinase 1 and 2 (ERK1/2) and phosphoinositide 3-kinase (PI3K)–Akt–mammalian target of rapamycin (PI3K-Akt-mTOR) pathways. Furthermore, fucoidan decreases the cytosolic and nuclear levels of Nuclear Factor-kappa B (p65). The present study suggests that fucoidan exhibits anti-metastatic effect on A549 lung cancer cells via the down-regulation of ERK1/2 and Akt-mTOR as well as NF-kB signaling pathways. Hence, fucoidan can be considered as a potential therapeutic reagent against the metastasis of invasive human lung cancer cells.

15 March 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
CZChangqing Zeng
Changqing Zeng
EKEuikyung Kim
Euikyung Kim
SWStephen L. Warren
Stephen L. Warren
SBSusan M. Berget
Susan M. Berget
Recent interest in understanding the spatial organization of gene expression has focused attention on nuclear structures known as speckles or interchromatin granule clusters (IGCs) revealed by immunofluorescence or electron microscopy. Staining of nuclear factors involved in pre‐mRNA splicing or, more recently, transcription, reveals 20–40 speckles per nucleus, resulting in the intriguing suggestion that speckles are nuclear sites of transcription and processing. In contrast, other investigations have observed transcription in other areas of the nucleus. In this study, we have examined the localization of active transcription as detected by uridine incorporation and recently developed RNA polymerase II antibodies, and compared this pattern with that of known splicing and polyadenylation factors. Our results indicate that in actively transcribing cells, transcription and splicing factors are dispersed throughout the nucleus with abundant sites of preferred localization. In contrast, in poorly transcribing cells, polymerase II and splicing factors localize to speckles. In nuclei inactivated for transcription by drugs or heat shock, the speckle type of co‐localization is accentuated. These observations suggest that bulk transcription and splicing occur throughout the nucleus during periods of active transcription; and that factors involved in these two processes re‐locate to minimal speckle domains during periods of inactive transcription.

1 December 2012 in Food Chemistry
Verified
Journal Article
Closed access
CKChangkeun Kang
Changkeun Kang
HLHyunkyoung Lee
Hyunkyoung Lee
EJEun-Sun Jung
Eun-Sun Jung
RSRamin Seyedian
Ramin Seyedian
MJMiNa Jo
MiNa Jo
EKEuikyung Kim
Euikyung Kim

1 September 2011 in Toxicon
Verified
Journal Article
Closed access
HLHyunkyoung Lee
Hyunkyoung Lee
EJEun-Sun Jung
Eun-Sun Jung
CKChangkeun Kang
Changkeun Kang
WYWon Duk Yoon
Won Duk Yoon
JKJong-Shu Kim
Jong-Shu Kim
EKEuikyung Kim
Euikyung Kim

1 July 2009 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
CKChangkeun Kang
Changkeun Kang
AL MUNAWIRAL MUNAWIR
AL MUNAWIR
MCMijin Cha
Mijin Cha
ESEun-Tae Sohn
Eun-Tae Sohn
HLHyunkyoung Lee
Hyunkyoung Lee
EKEuikyung Kim
Euikyung Kim